Jin et al reported that suppressing the Glycoprotein non-metastatic melanoma protein B (GPNMB) would inhibit osteosarcoma cell proliferation and metastasis via blocking PI3K/Akt/mTOR signaling pathway [43]. The gene discussed is AKT1; the disease is osteosarcoma.